PDCD1 and neoplasm: The co-delivery of tumor anti-CTLA-4, anti-PD-1, and tumor vaccines using injectable PEG-b-poly(L-alanine) hydrogels increased the efficacy of immunotherapy by reducing the number of Tregs and increasing the number of activated CD8+ T cells in the TME (60).